Innovators Award - Marfan Foundation
This grant funds innovative translational research to improve understanding, diagnosis, and treatment of Marfan syndrome and related genetic vascular disorders.
Funder: Marfan Foundation
Due Dates (Anticipated): October 2026 (full application deadline, projected)
Funding Amounts: $100,000 total over 2 years ($50,000/year); no indirect costs allowed
Summary: Supports innovative, faculty-led translational research to advance diagnostics, therapies, and biomedical understanding of Marfan syndrome and related genetic vascular conditions.
Key Information: No institutional overhead/indirect costs permitted; open to international applicants with MD, PhD, or equivalent.
Description
This award supports faculty investigators proposing innovative translational science projects with the potential to improve human health, particularly in the context of Marfan syndrome, Loeys-Dietz syndrome, Vascular Ehlers-Danlos syndrome (VEDS), and other genetic aortic and vascular conditions. The program encourages research in fundamental science, diagnostic test development, biomarker discovery, biomedical engineering, imaging technologies, and the collection of data to refine evidence-based medical guidance. Projects may span basic, translational, or clinical research, with a strong emphasis on novel approaches and significant impact.
